ALNYLAM PHARMACEUTICALS INC (ALNY) Institutional Ownership and Insiders Activity

ALNYLAM PHARMACEUTICALS INC (ALNY) is widely held by institutional investors, with 717 firms reporting positions valued at approximately $29.66B based on SEC Form 13F filings for the quarter ended September 30, 2026.

Capital World Investors is the largest disclosed holder, reporting approximately $3.41B in ALNY holdings in its latest filing.

Recent insider activity includes 5 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.

Institutional Holders

717

Total Reported Value

$29.66B

Largest Holder

Capital World Investors

Largest Position

$3.41B

Insider Transactions (90d)

5

Latest Filing Quarter

Q3 2026

New Institutional Positions

813

Funds Exiting Positions

2